Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
which harbor FLT3-ITD
Small Molecule-Mediated TGF-β Type II Receptor Degradation Promotes Cardiomyogenesis in Embryonic Stem Cells
InChiKey: YGUIFRMUMYTGAV-VIFPVBQESA-N
focal adhesion kinase (FAK)
Khardin is a bioactive chemical
Linagliptin Catalog No.:M10654-10 which harbor FLT3-ITDLinagliptin, also known as BI 1356, is a DPP 4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly. Product information CAS Number: 668270 12 0 Molecular Weight: 472. 54 Formula: C25H28N8O2 Chemical Name: 8 [(3R) 3 aminopiperidin 1 yl] 7 (but 2 yn 1 yl) 3 methyl 1 [(4